Latest news

NEURODEGENERATIVE DISEASE COSTS EXCEED $655 BILLION A YEAR IN MEDICAL EXPENSES AND ECONOMIC LOSSES
Lack of cures combined with minimal viable treatments compounds increasing health and caregiving costs   May 27, 2021 (WASHINGTON, D.C.) The Partnership to Fight Chronic Disease (PFCD) today released a literary review and infographic data on Alzheimer’s disease and related dementias (
Press release
May 27,2021
Eliminating Disability Bias
The following Letter to the Editor was published in the May 2021 issue of Health Affairs.   Lisa Iezzoni and coauthors (Feb 2021) exposed what people living with disabilities experience daily: inherent bias within health care due to misperceptions about their quality of
OP-ED
May 17,2021
Biopharmaceutical industry exceeded wildest expectations
By Kenneth E. Thorpe May 11, 2021 Boston Herald    In less than a year after the pandemic began, Americans have access to three highly effective vaccines that can pave the way forward and away from COVID-19, and that number could soon rise, as the FDA considers promising candidates
OP-ED
May 11,2021
Partnership to Fight Chronic Disease Statement Regarding Biden Administration’s Support of Waiving IP Protections for COVID-19 Vaccines
WASHINGTON, D.C. (May 6, 2021) Kenneth Thorpe, chairman of the Partnership to Fight Chronic Disease (PFCD), has issued the following statement in response to the Biden Administration’s announcement in support of waiving intellectual property (IP) protections for COVID-19 vaccines:  
Press release
May 6,2021
America Follow Europe's Lead: Patents Protect Patients Globally
By Kenneth E. Thorpe April 29, 2021   The World Trade Organization is considering a petition from several dozen countries to nullify intellectual property protections on Covid-19 vaccines. Supporters claim the move will expand global access to vaccines.   The United
OP-ED
Apr 29,2021
NEW ANALYSIS OF MEDICAID SPENDING REINFORCES VALUE AND PATIENT IMPACT OF FDA ACCELERATED APPROVAL PATHWAY
Data support preserving access to accelerated approval drugs for the seriously ill   Commentary in the American Journal of Managed Care warns that restricting access to accelerated approval therapies has minimal budget implications, but poses significant harm to patients   March 30,
Press release
Mar 30,2021
Biden administration needs a national pandemic preparedness strategy
Defeating this scourge will be the President-elect's greatest challenge By Kenneth E. Thorpe - - Wednesday, December 16, 2020   ANALYSIS/OPINION:   COVID-19 has killed more than 300,000 Americans. And with case counts and hospitalizations soaring, many
OP-ED
Dec 17,2020
The pandemic is making Americans afraid of going to the doctor for any reason at all
Sacrificing regular doctor visits in order to socially distance is not a good idea. Here’s why By KENNETH E. THORPE DECEMBER 6, 2020 7:00PM (UTC) Millions of Americans have postponed lifesaving screenings and other preventative care due to COVID-19, according to an
OP-ED
Dec 8,2020
After taming the COVID outbreak, focus on antibiotics to fight superbugs
By KENNETH E. THORPE ORLANDO SENTINEL  DEC 07, 2020 AT 5:30 AM     The end of the COVID-19 pandemic is finally in sight.   Pfizer recently announced that its
OP-ED
Dec 8,2020
TRUMP ADMINISTRATION'S DRUG REBATE REFORM OFFERS RELIEF FOR CHRONICALLY ILL
WASHINGTON, D.C. (November 20, 2020) The Partnership to Fight Chronic Disease has issued the following statement in response to the Trump Administration’s Final Rule to extend benefits of drug rebates to Medicare beneficiaries:   “Rebates lower drug costs for insurers, but
Press release
Nov 20,2020

Pages